
Sanjay Basu on affordable T2D medicine in LMICs
0:00
9:42
Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries.
Read the full article:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00240-0/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Weitere Episoden von „The Lancet Diabetes & Endocrinology in conversation with“
Verpasse keine Episode von “The Lancet Diabetes & Endocrinology in conversation with” und abonniere ihn in der kostenlosen GetPodcast App.